Akèy › Ipètansyon Okilè › Texas
Etid klinik pou Ipètansyon Okilè nan Texas
8 etid pou Ipètansyon Okilè ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
iDose TR Administration in an Office-Based Surgery Setting
- Glaukos Investigative Site, Austin
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07816692A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- Houston Eye Associates, Houston
- R and R eye research, San Antonio
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07661329Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Glaukos Clinical Site, El Paso
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
- Ophthalmology Associates, Fort Worth
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT04967989Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
Ap rekriteFaz 3
Laj 22 ak plis · Tout sèks · Mizajou Oct 20, 2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
Ap rekriteFaz 3
Laj 22 ak plis · Tout sèks · Mizajou Oct 20, 2025 · NCT07218783Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
- Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2023 · NCT05844384Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Keystone Research, Austin
- Houston Eye Associates, North Loop, Houston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2022 · NCT05401357Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.